All
All

What are you looking for?

All
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

The role of Akt kinase in the regulation of G2/M cell cycle transition and in the acquisition of developmental potency of oocytes

Project goals

In the proposed project regulation of G2/M checkpoint of meiotic cell cycle will be addressed in order to assess the relevance of these events for improvement of oocyte quality and developmental potency of early embryos. The data issued from this studywill also contribute to the understanding of cell cycle regulation. For this purpose the role of Akt kinase, an upstream regulator of p34cdc2 kinase, will be analysed during meiosis progression. To achieve this goal the experimental model of in vitromaturation of mouse, porcine and cattle oocytes will be used . Detailed analysis of expression, activation and localisation of Akt kinase and downstream Wee1 kinase family during meiosis progression will be performed. Dynamics of p34cdc2 kinaseactivation willbe documented as well. Subsequently, specific inhibitors of Akt kinase activity will be used during in vitro culture in order to affect cytoplasmic maturation and to improve quality of oocytes. The impact of inhibition of Akt kinase upon

Keywords

Public support

  • Provider

    Czech Science Foundation

  • Programme

    Standard projects

  • Call for proposals

    Standardní projekty 2 (SGA02003GA-ST)

  • Main participants

    Ústav živočišné fyziologie a genetiky AV ČR, v. v. i.

  • Contest type

    VS - Public tender

  • Contract ID

Alternative language

  • Project name in Czech

    Úloha Akt kinázy pro regulaci G2/M fáze buněčného cyklu a získání vývojové kompetence oocytů

  • Annotation in Czech

    Navrhovaný projekt se zabývá regulací G2/M fáze meiotického buněčného cyklu s cílem využít tyto poznatky pro zvýšení kvality zralých oocytů a vývojového potenciálu časných embryí. Údaje získané při řešení tohoto projektu také přispějí k poznání regulacebuněčného cyklu. Za tímto účelem bude v průběhu meiotického zrání analyzována úloha kinázy Akt (protein kináza B), která reguluje aktivitu p34cdc2 kinázy. Pro řešení tohoto úkolu bude používán in vitro model meiotického zrání oocytů myši, prasete askotu.V závislosti na jednotlivých stádiích meiózy bude provedena podrobná analýza exprese, aktivace a lokalizace Akt kinázy a jí podřízených Wee1 kináz, jakož i bude podrobně dokumentována dynamika aktivity p34cdc2 kinázy. V návazných experimentechbudou při kultivaci oocytů použity specifické inhibitory Akt kinázy s cílem ovlivnit cytoplasmatické zrání a zvýšit kvalitu oocytů. Bude provedena morfologická a biochemická analýza účinku inhibice kinázy Akt v průběhu meiotického zrání oocytů myši,

Scientific branches

  • R&D category

    ZV - Basic research

  • CEP classification - main branch

    ED - Physiology

  • CEP - secondary branch

    EI - Biotechnology and bionics

  • CEP - another secondary branch

    GI - Farm animal breeding and farm animal pedigree breeding

  • 20801 - Environmental biotechnology
    20802 - Bioremediation, diagnostic biotechnologies (DNA chips and biosensing devices) in environmental management
    20803 - Environmental biotechnology related ethics
    20901 - Industrial biotechnology
    20902 - Bioprocessing technologies (industrial processes relying on biological agents to drive the process) biocatalysis, fermentation
    20903 - Bioproducts (products that are manufactured using biological material as feedstock) biomaterials, bioplastics, biofuels, bioderived bulk and fine chemicals, bio-derived novel materials
    30105 - Physiology (including cytology)
    30401 - Health-related biotechnology
    30402 - Technologies involving the manipulation of cells, tissues, organs or the whole organism (assisted reproduction)
    30403 - Technologies involving identifying the functioning of DNA, proteins and enzymes and how they influence the onset of disease and maintenance of well-being (gene-based diagnostics and therapeutic interventions [pharmacogenomics, gene-based therapeutics])
    30404 - Biomaterials (as related to medical implants, devices, sensors)
    30405 - Medical biotechnology related ethics
    40203 - Husbandry
    40401 - Agricultural biotechnology and food biotechnology
    40402 - GM technology (crops and livestock), livestock cloning, marker assisted selection, diagnostics (DNA chips and biosensing devices for the early/accurate detection of diseases) biomass feedstock production technologies, biopharming
    40403 - Agricultural biotechnology related ethics

Completed project evaluation

  • Provider evaluation

    U - Uspěl podle zadání (s publikovanými či patentovanými výsledky atd.)

  • Project results evaluation

    Phosphorylation and activation of protein kinase Akt (protein kinase B) was evaluated during meiotic maturation of mouse and porcine oocytes. At germinal vesicle breakdown (GVBD) of mouse oocytes the phosphorylation and activity of Akt/PKB was increased

Solution timeline

  • Realization period - beginning

    Jan 1, 2003

  • Realization period - end

    Jan 1, 2005

  • Project status

    U - Finished project

  • Latest support payment

Data delivery to CEP

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

  • Data delivery code

    CEP06-GA0-GA-U/07:6

  • Data delivery date

    Jan 15, 2009

Finance

  • Total approved costs

    2,745 thou. CZK

  • Public financial support

    1,860 thou. CZK

  • Other public sources

    885 thou. CZK

  • Non public and foreign sources

    0 thou. CZK

Basic information

Recognised costs

2 745 CZK thou.

Public support

1 860 CZK thou.

67%


Provider

Czech Science Foundation

CEP

ED - Physiology

Solution period

01. 01. 2003 - 01. 01. 2005